HISAMITSU PHARMACEUTICAL CO.,INC.【JP:4530】Cash flow
Market cap
¥548.5B
P/E ratio
21.2x
| 2015/02 | 2016/02 | 2017/02 | 2018/02 | 2019/02 | 2020/02 | 2021/02 | 2022/02 | 2023/02 | 2024/02 | 2025/02 | |
| Depreciation & amortization | 6,667 | 7,477 | 6,438 | 6,005 | 5,742 | 4,251 | 4,079 | 4,321 | 4,952 | 5,110 | 6,185 |
| Cash from operations | 23,232 | 30,923 | 19,910 | 30,453 | 15,772 | 27,395 | 5,289 | 19,199 | 12,727 | 18,188 | 18,765 |
| Capital expenditures | -4,691 | -5,052 | -3,125 | -3,131 | -3,626 | -3,698 | -3,341 | -3,610 | -7,859 | -12,924 | -13,627 |
| Cash from investing | -8,945 | -3,912 | 1,070 | -1,378 | -39,302 | -17,229 | 7,815 | -13,060 | -23,868 | -2,512 | 17,563 |
| Payments for dividends | -6,642 | -7,067 | -6,944 | -6,855 | -6,882 | -6,836 | -6,806 | -6,839 | -6,719 | -6,578 | -6,519 |
| Repurchases of common stock | -1 | -4,178 | -11,153 | -2 | -6,176 | -4,520 | -2 | -8,043 | -7,694 | -9,796 | -10,554 |
| Proceeds from issuance of term debt, net | - | 244 | - | - | - | - | - | - | - | - | 1,830 |
| Repayments of term debt | -137 | -370 | -78 | -71 | -71 | -67 | -69 | -77 | -71 | -66 | -217 |
| Cash from financing | -7,036 | -11,616 | -18,402 | -7,153 | -13,347 | -11,726 | -7,187 | -15,189 | -14,687 | -16,691 | -15,850 |
| Free cash flow | |||||||||||
| FCF margin (%) |